Page 22«..10..21222324..»

Category Archives: Epigenetics

Cambridge Epigenetix and NuGEN Technologies Sign Agreement … – Technology Networks

Posted: August 19, 2017 at 5:42 pm

Co-exclusive global licence covers manufacture and integration of CEGX TrueMethyl technology for oxidative bisulfite sequencing (oxBS-Seq) with Targeted Methylation and NuGEN Ovation Methyl-Seq systems.

Cambridge Epigenetix (CEGX) and NuGEN Technologies, leaders in innovative epigenetic technologies, have announced that they have entered into a partnership agreement to integrate the CEGX TrueMethyl technology for oxidative bisulfite sequencing (oxBS-Seq) with NuGENs innovative NGS library preparation kits. The signing of the agreement will enable CEGX to focus on its epigenetic biomarker discovery programmes, both in-house and in partnership with leading biopharma companies, and will further strengthen NuGENs epigenetics portfolio of whole genome Methyl-Seq, Reduced Representation Bisulfite Sequencing (RRBS), and patented SPET target enrichment systems.

The epigenetic DNA modifications 5-hydroxymethylcytosine (5hmC) and 5-methylcytosine (5mC) play very different roles in gene regulation. Cambridge Epigenetix enhanced the appreciation of 5hmC through the introduction of its TrueMethyl oxBS-Seq system. Their developments have enabled researchers to further elucidate the role of DNA methylation in disease occurrence and progression, highlighting the potential for such epigenetic marks in the development of improved diagnostic and prognostic assays. The integration of TrueMethyl oxBS and NuGENs patented library preparation technologies will broaden the scope of accessible samples for the detection of these emerging markers.

Jason Mellad, CEO at Cambridge Epigenetix, commented: This partnership will enable both CEGX and NuGEN to leverage our strengths to facilitate advances in the epigenetics field. CEGX is committed to realising the promise of epigenetics through the development of improved, minimally invasive diagnostic and prognostic tests for accurate and early detection of a range of diseases, including cancer. We are working with leading biopharma companies as well as progressing our own high-value internal programmes, applying our expertise and advanced proprietary technology for robust biomarker identification, particularly from liquid biopsy samples. NuGENs reach and reputation for delivering high-quality genomics solutions to the market makes them the ideal partner to further develop TrueMethyl technology to deliver a range of new products to enhance epigenetics research.

Nitin Sood, CEO at NuGEN Technologies, said: We are delighted to be working with CEGX to provide the tools to improve the understanding and appreciation of epigenetics in cellular function. The goal of all of our products has always been to maximize the information that our customers obtain from their nucleic acid samples. By combining the TrueMethyl oxBS technology with our NGS library preparation kits, we will provide our customers with whole genome and targeted methylation products to unlock the tremendous potential of epigenetics. The combination provides access to more detailed, higher resolution epigenetic information in an integrated, cost-effective solution. The technology complements our Methyl-Seq and Single Primer Enrichment Technology product lines, and we are delighted to provide researchers with the most comprehensive solution for epigenetics research.

New products resulting from this partnership are anticipated by the end of the year and will be available directly from NuGEN. TrueMethyl products should still be ordered through CEGX until further notice. For more information about TrueMethyl, including how to order, please visit https://www.cambridge-epigenetix.com/products.

Read more from the original source:
Cambridge Epigenetix and NuGEN Technologies Sign Agreement ... - Technology Networks

Posted in Epigenetics | Comments Off on Cambridge Epigenetix and NuGEN Technologies Sign Agreement … – Technology Networks

More Than Just Genes: How Environment, Lifestyle, and Stress Impact ADHD – ADDitude

Posted: August 19, 2017 at 5:42 pm

Our understanding of ADHD has grown by leaps and bounds over the past 30 years. What started as hyperkinetic impulse disorder its primary symptom excessive hyperactivity over time shifted to attention deficit disorder and a focus on problems with inattention, then to reward functioning, and later to executive functioning. None of these translations was wrong, in and of itself;each set of highlighted symptoms is a distinct and important part of the disorder we now call ADHD. But the facets were poorly integrated with one another, and thus painted an incomplete picture of a highly complex condition.

Now, researchers understand that ADHD is primarily a disorder of self-regulation. Self-regulation weaves together all the older theories of ADHD into one cohesive picture; it is also what allows humans to manage impulses, engage or disengage attention, and navigate between deliberate and automatic responses to different situations. The ability to self-regulate is managed across the brain in highly interconnected ways; similar brain nodes regulate both attention and emotion and when one area isnt performing well, the others suffer, too.

The newest theories of ADHD, then, dont focus on a single underperforming area of the brain, as older ones did. Its now understood that ADHD manifests when neurons misfire in the ever-shifting communications and connections between multiple areas of the brain. Emerging research also suggests that these neurological wrinkles may be driven by the environment as much (or more) than they are by genes.

[Quiz: Can You Tell the Difference Between ADHD Myths and ADHD Facts?]

This new framework provides a much more nuanced and complex view of ADHD, but it also provides hope: If ADHD symptoms can be worsened by environmental causes, they can be improved by them, too. Read on to find out how.

Researchers have long known that ADHD can be passed down genetically. But the idea that we can find the single gene responsible for ADHD and fix it is now understood to be outdated. The newest theory of ADHD, as a disorder primarily related to self-regulation, relies on something called epigenetics.

Epigenetics refers to biological traits or changes that cannot be explained by a persons genetic code. Epigenetic mechanisms actually create a physical mark on the DNA when a person undergoes an important experience, whether its positive or negative. These marks which can be added methyl molecules, or a modified histone tail adjust the individuals gene function, changing what the genes do or how strongly they express themselves. In a nutshell, environment and experiences affect a humans development and behavior in an enduring fashion actually altering regions of DNA, with effects that may last for an entire lifetime.

How does it work? It starts with genes the building blocks of who we are and who we become. But beginning at conception, everyone is exposed to different environmental toxins and advantages and after were born, psychological inputs like stress, adversity, and even trauma begin to factor in. Epigenetics takes this input and uses it to change how genes are expressed meaning a genes output isnt fully known until environment and personal history are factored in.

[Free Resource: What to Eat (and Avoid) for Improved ADHD Symptoms]

Epigenetics paints a much more complicated view of ADHD, but also a much more optimistic one; genes do not solely determine an individuals fate. In fact, while genes may make someone more prone to certain diseases or disorders, including ADHD, the entire genetic system is highly dynamic and responsive to input. This means its possible to change the expression of a persons ADHD genes by making certain environmental changes.

Credible and robust epigenetics research confirms these assertions. One experiment1 took two genetically identical mice embryo and, during the prenatal stage, fed their mothers diets that included the toxic element bisphenol-A (BPA). The diet of one mouses mother, however, was supplemented with nutrients like choline, folic acid, and B12; that mouse was later able to avoid the negative effects of the BPA, including obesity and a higher risk of cancer. This phenomenon can be explained by epigenetics the additional nutrients were able to turn off the genes that respond to BPA, and thus protect the mouse from its harmful effects.

Another experiment2 this one involving humans tested whether taking an omega-3 supplement during pregnancy would impact the attention abilities of a mothers child. The study found that children whose mothers had randomly received the supplement had stronger attention at 6 and 12 months, and later had better-developed mental abilities, than did children whose mothers had not taken the supplement. Since this experiment was randomized and the effect was so great, researchers were able to determine a causal effect and again, one that was influenced by epigenetics. Food dyes, artificial preservatives, and lead yielded similar results3 the introduction of each into a childs pre- or post-natal environment had real, causal effects on his or her attention, hyperactivity, and emotional regulation.

Similar experiments have been done on stress and adversity and how exercise can counteract those negative effects. One experiment4 placed rats into a stressful situation for a period of time each day, which resulted in significant epigenetic changes that decreased healthy function. However, when those same rats were also allowed to exercise while still experiencing the stressor the negative effects on the brain were completely eliminated. The study provided a clear example of how exercise can reverse the harmful brain-based effects of a negative early-life experience.

[Daily Exercise Ideas to Boost Focus]

This research suggests that lifestyle changes may help to offset the effects of ADHD genes activated by genetic, chemical, dietary, or other factors. More epigenetic research is needed, however a few things are clear: Omega-3 supplementation, aerobic exercise, and stress management can have real, positive effects on ADHD symptoms in both children and adults.

How big are these effects? Some changes, like reducing the amount of TV a child watches each day, have very small effects on ADHD symptoms only slightly noticeable in a familys everyday life. Others, like increasing omega-3 intake or introducing an exercise regimen, have significantly larger effect sizes up to twice or three times as large as reducing screen time.

Researchers now recommend that anyone with ADHD follows these strategies:

Continuing research is creating an ever-growing body of evidence regarding which lifestyle changes improve ADHD symptoms, and which are less useful. Though findings are still preliminary, the evidence is already strong enough to make them actionable. Simple changes, like exercising more or taking a fish oil supplement, can have real, lasting effects on an individuals ADHD symptoms in other words, genes do not seal your fate.

Learn more in Dr. Niggs book, Getting Ahead of ADHD: What Next-Generation Science Says about Treatments That Work and How You Can Make Them Work for Your Child

1Dolinoy DC, Huang D, Jirtle RL. Maternal Nutrient Supplementation Counteracts Bisphenol A-Induced DNA Hypomethylation in Early Development. PNAS, vol. 104, 2007, pp. 1305613061.2Colombo, John, et al. Maternal DHA and the Development of Attention in Infancy and Toddlerhood. Child Development, vol. 75, no. 4, 2004, pp. 12541267., doi:10.1111/j.1467-8624.2004.00737.x.3 Stevenson, J, et al. The Role of Histamine Degradation Gene Polymorphisms in Moderating the Effects of Food Additives on Childrens ADHD Symptoms. The American Journal of Psychiatry, vol. 167, no. 9, Sept. 2010, pp. 11081115.4 Kashimoto, R.K., et al. Physical Exercise Affects the Epigenetic Programming of Rat Brain and Modulates the Adaptive Response Evoked by Repeated Restraint Stress. Behavioural Brain Research, vol. 296, 2016, pp. 286289., doi:10.1016/j.bbr.2015.08.038.

Read more here:
More Than Just Genes: How Environment, Lifestyle, and Stress Impact ADHD - ADDitude

Posted in Epigenetics | Comments Off on More Than Just Genes: How Environment, Lifestyle, and Stress Impact ADHD – ADDitude

‘Magical’ Mushroom Could Fight off Cancer with Epigenetics – WhatIsEpigenetics.com

Posted: August 19, 2017 at 5:42 pm

A certain type of mushroom might epigenetically prevent tumor growth, according to a study published in the Journal of Cancer Research and Treatment. A medicinal mushroom, Phellinus linteus (PL), could come with magical anticancer properties. Researchers from New York Medical College found that histone deacetylase (HDAC) inactivation and histone acetylation led to the death of bladder cancer cells.

Chemotherapy and immunotherapy often come with severe side effects, and for those suffering from bladder cancer, the use of these therapies is limited and often ineffective in the long run. Because of this, a group of scientists sought to find a possible alternative therapy, one that relies on extracts of a very special type of fungus.

According to the researchers, Phellinus linteus has been used in Asian countries for centuries to prevent or treat ailments, including gastroenteric dysfunction, diarrhea, hemorrhage, rheumatoid arthritis, and cancers. In the wild, this mushroom can be found growing on mulberry trees. Interestingly, it is consumed in the form of hot tea in Korean traditional medicine.

Previous articles on What is Epigenetics detail the epigenetic effects and potential cancer-fighting benefits of broccoli, fruits, and other plants. Research has even found that a natural compound in cypress trees could protect against cancer and that green tea might be able to turn genes on or off in women. However, we are still in the beginning stages of understanding and researching these effects and whether they translate to humans in a practical manner.

Now the focus is on mushrooms. The group of researchers aimed to measure the epigenetic effect of this well-known mushroom on the growth of urothelial cell carcinoma(UCC), the most common type of bladder cancer. Those suffering from this particular cancer have limited therapeutic options. Often, the tumor returns, and the side effects brought on by chemotherapy or immunotherapy are a significant drawback.

In one of the first studies assessing the potential benefits of mushrooms against bladder cancer, these researchers found that the growth of human cancer cells was reduced from 60 to 90 percent and that histone deacetylase activity was significantly lost. The results were obtained by examining the effects of three distinct PL extracts on UCC cells in vitro.

HDACs are epigenetic enzymes that remove chemical groups, known as acetyl groups, from histone proteins. DNA wraps around these histones and the expression of our genes is changed depending on how loose or tight the structure is. Read more about chromatin remodeling and the impact it has on gene expression.

Removing an acetyl group will allow the histones to wrap around the DNA more tightly, which will prevent the expression of certain genes. Often times, cancer cells are treated with HDAC inhibitors (HDACi) because HDACs can cause aberrant transcription of key genes that regulate cell functions often linked to cancer, such as cell proliferation, cell-cycle regulation, and apoptosis.

In this study, HDAC activity was reduced as a result of cancerous cells being treated with mushroom extracts and histone acetylation was increased. The researchers used the Epigenase HDAC Activity/Inhibition Direct Assay Kit from EpiGentek to measure HDAC activity. They found that greater than 60% of HDAC activity was reduced after treatment with three distinct extracts or fractions of the mushroom (PL-I, -II, and -III). In addition, both histones H3 and H4 were highly acetylated, which indicated alterations in the chromatin structure.

The present study shows that all three PL-fractions, PL-I, -II, and -III, have anticancer effects on [bladder cancer] cells, although PL-III appears to be the most potent, reported the researchers. Such an anticancer mechanism is attributed to a p21-mediated cell cycle arrest with epigenetic modifications involving HDAC inactivation and hyperacetylation of H3 and H4, ultimately leading to apoptotic cell death.

Overall, the mushroom extracts reduced cell viability through anticancer activity, and histone modifications were thought to induce cell cycle arrest. In light of these results, this mushroom could modify the chromatin structure consisting of histones and DNA ultimately reducing cancer cell viability via a cell cycle arrest. The researchers suggest that DNA methylation, another popular epigenetic mechanism, should be investigated in terms of possible epigenetic effects of these fungus fractions.

This study raises new questions about whether nontraditional medicines could help those suffering from cancer. As we continue to conduct more research and investigate the epigenetic effects of various natural substances on human health and well being, we can begin to understand the potential benefits of alternative medicine and consider developing new therapies in the future.

Source: Bhalodi, A. et al. (2016). Alternative Therapeutic Approach to Urothelial Cell Carcinoma with Medicinal Mushroom Extracts. Journal of Cancer Research and Treatment, 4(5): 73-79.

See original here:
'Magical' Mushroom Could Fight off Cancer with Epigenetics - WhatIsEpigenetics.com

Posted in Epigenetics | Comments Off on ‘Magical’ Mushroom Could Fight off Cancer with Epigenetics – WhatIsEpigenetics.com

Epigenetics: How Your Mind Can Reprogram Your Genes

Posted: August 14, 2017 at 2:47 am

By Dr. Mercola

How much control do you really have over your own life in general, and your health in particular? These questions have puzzled many since the beginning of time. Now, the emerging science of epigenetics is offering some answers that put true control within your reach.

According to some scientists, changing your health may be as "simple" as changing your thoughts and beliefs.

"Contrary to what many people are being led to believe, a lot of emphasis placed on genes determining human behavior is nothing but theory and doctrine," writes Konstantin Erikseni . "We are free to make decisions that impact our lives and those of others. Our beliefs can change our biology. We have the power to heal ourselves, increase our feelings of self-worth and improve our emotional state."

Eriksen goes on to discuss something called "The Central Dogma" of molecular biology, which states that biological information is transferred sequentially and only in one direction (from DNA to RNA to proteins).

The ramification of buying into the central dogma is that it leads to belief in absolute determinism, which leaves you utterly powerless to do anything about the health of your body; it's all driven by your genetic code, which you were born with.

However, scientists have completely shattered this dogma and proven it false. You actually have a tremendous amount of control over how your genetic traits are expressedfrom how you think to what you eat and the environment you live in.

You may recall the Human Genome Projectii , which was launched in 1990 and completed in 2003. The mission was to map out all human genes and their interactions, which would than serve as the basis for curing virtually any disease. Alas, not only did they realize the human body consists of far fewer genes than previously believed, they also discovered that these genes do not operate as previously predicted.

In the featured article, Eriksen describes the experiments of John Cairns, a British molecular biologist who in 1988 produced compelling evidence that our responses to our environment determine the expression of our genes. A radical thought, for sure, but one that has been proven correct on multiple occasions since then.

Eriksen writesiii :

"Cairns took bacteria whose genes did not allow them to produce lactase, the enzyme needed to digest milk sugar, and placed them in petri dishes where the only food present was lactase. Much to his astonishment, within a few days, all of the petri dishes had been colonized by the bacteria and they were eating lactose. The bacterial DNA had changed in response to its environment. This experiment has been replicated many times and they have not found a better explanation than this obvious fact that even primitive organisms can evolve consciously.

So, information flows in both directions, from DNA to proteins and from proteins to DNA, contradicting the "central dogma." Genes can be activated and de-activated by signals from the environment. The consciousness of the cell is inside the cell's membrane. Each and every cell in our bodies has a type of consciousness. Genes change their expression depending on what is happening outside our cells and even outside our bodies."

As if genes changing expression in response to environmental factors such as nutrients wasn't enough, other researchers have demonstrated that this "environment" that your genes respond to also includes your conscious thoughts, emotions, and unconscious beliefs. Cellular biologist Bruce Lipton, PhD., is one of the leading authorities on how emotions can regulate genetic expression, which are explained in-depth in his excellent books The Biology of Belief, and Spontaneous Evolution.

Science has indeed taken us far beyond Newtonian physics, which says you live in a mechanical universe. According to this belief, your body is just a biological machine, so by modifying the parts of the machine, you can modify your health. Also, as a biological machine, your body is thought to respond to physical "things" like the active chemicals in drugs, and by adjusting the drugs that modify your machinery, doctors can modify and control health. However, with the advent of quantum physics, scientists have realized the flaws in Newtonian physics, as quantum physics shows us that the invisible, immaterial realm is actually far more important than the material realm. In fact, your thoughts may shape your environment far more than physical matter!

According to Dr. Lipton, the true secret to life does not lie within your DNA, but rather within the mechanisms of your cell membrane.

Each cell membrane has receptors that pick up various environmental signals, and this mechanism controls the "reading" of the genes inside your cells. Your cells can choose to read or not read the genetic blueprint depending on the signals being received from the environment. So having a "cancer program" in your DNA does not automatically mean you're destined to get cancer. Far from it. This genetic information does not ever have to be expressed...

What this all means is that you are not controlled by your genetic makeup. Instead, your genetic readout (which genes are turned "on" and which are turned "off") is primarily determined by your thoughts, attitudes, and perceptions!

The major problem with believing the myth that your genes control your life is that you become a victim of your heredity. Since you can't change your genes, it essentially means that your life is predetermined, and therefore you have very little control over your health. With any luck, modern medicine will find the gene responsible and be able to alter it, or devise some other form of drug to modify your body's chemistry, but aside from that, you're out of luck The new science, however, reveals that your perceptions control your biology, and this places you in the driver's seat, because if you can change your perceptions, you can shape and direct your own genetic readout.

This new science also reveals that you are in fact an extension of your environment, which includes everything from your thoughts and belief systems, to toxic exposures and exposure to sunlight, exercise, and, of course, everything you choose to put onto and into your body. As Dr. Lipton is fond of saying, the new biology moves you out of victimhood and into Masterymastery over your own health.

It is a supreme confirmation of my favorite saying, "You Can Take Control of Your Health."

Two years ago, a study performed by the Linus Pauling Institute at Oregon State University was showcased at the annual Experimental Biology convention. The study demonstrated how "histone modifications" can impact the expression of many degenerative diseases, ranging from cancer and heart disease to biopolar disorder and even aging itself. According to Rod Dashwood, a professor of environmental and molecular toxicology and head of LPI's Cancer Chemoprotection Program, as quoted in a press releaseiv:

"We believe that many diseases that have aberrant gene expression at their root can be linked to how DNA is packaged, and the actions of enzymes such as histone deacetylases, or HDACs. As recently as 10 years ago we knew almost nothing about HDAC dysregulation in cancer or other diseases, but it's now one of the most promising areas of health-related research."

In a nutshell, we all have tumor suppressor genes, and these genes are capable of stopping cancer cells in their tracks. These genes are present in every cell in your body, but so are proteins called "histones." As Dr. Jean-Pierre Issa at the M.D. Anderson Cancer Center explainsv , histones can "hug" DNA so tightly that it becomes "hidden from view for the cell." If a tumor suppressor gene is hidden, it cannot be utilized, and in this way too much histone will "turn off" these cancer suppressors, and allow cancer cells to proliferate.

Now here's where epigenetics comes in certain foods, such as broccoli and other cruciferous vegetables, garlic, and onions contain substances that act as histone inhibitors, which essentially block the histone, allowing your tumor suppressor genes to activate and fight cancer. By regularly consuming these foods, you are naturally supporting your body's ability to fight tumors.

Certain alternative oncologists also tap directly into the epigenetic mechanism, such as Dr. Nicholas Gonzalez, who uses a three-pronged approach to cancer based primarily on nutrition and detoxification, and Dr. Stanislaw Burzynski, who treats cancer with a gene-targeted approach. His treatment uses non-toxic peptides and amino acids, known as antineoplastons, which act as genetic switches that turn your tumor suppressor genes "on."

So the good news is that you are in control of your genes You can alter them on a regular basis, depending on the foods you eat, the air you breathe, and the thoughts you think. It's your environment and lifestyle that dictates your tendency to express disease, and this new realization is set to make major waves in the future of disease prevention -- including one day educating people on how to fight disease at the epigenetic level. When a disease occurs, the solution, according to epigenetic therapy, is simply to "remind" your affected cells (change its environmental instructions) of its healthy function, so theycan go back to beingnormal cells instead of diseased cells.

You can begin to do this on your own, long before you manifest a disease. By leading a healthy lifestyle, with high quality nutrition, exercise, limited exposure to toxins, and a positive mental attitude, you encourage your genes to express positive, disease-fighting behaviors.

This is what preventive medicine is all about. It's not about taking any one particular nutrient as a supplement to fix one specific "part" of your biological machinery... The more people become willing to embrace this simple truth, the healthier everyone will get.

It's also worth pointing out that epigenetic effects begin before birth.

Epigenetic research from 2009 showed that rat fetuses receiving poor nutrition in the womb become genetically primed for a nutrition-poor environment. As a result of this genetic adaptation, the rats tended to be smaller. They were also at higher risk for a host of health problems throughout their lives, such as diabetes, growth retardation, cardiovascular disease, obesity, and neurodevelopmental delays. Again, while some are tempted to blame such "predispositions" on bad genes, the KEY factor is nutrition, i.e. the cellular environment.

If you're ready to address your dietary choices, read through my comprehensive nutrition plan, which will give you tips and tools for eating healthy, dealing with stress, and living a lifestyle that will support your epigenetic health.

You can also turn your genes off and on with your emotions too. Many, if not most people carry emotional scars; traumas that can adversely affect health. Using techniques like energy psychology, you can go in and correct the trauma and help regulate your genetic expression. My favorite technique for this is the Emotional Freedom Technique (EFT), but there are many others. Choose whichever one appeals to you, and if you don't sense any benefits, try another, until you find what works best for you.

Please, remember that 'You CAN Take Control of Your Health.'

References:

See the article here:
Epigenetics: How Your Mind Can Reprogram Your Genes

Posted in Epigenetics | Comments Off on Epigenetics: How Your Mind Can Reprogram Your Genes

A Super Brief and Basic Explanation of Epigenetics for …

Posted: August 14, 2017 at 2:47 am

In simplified terms, epigenetics is the study of biological mechanisms that will switch genes on and off. What does that mean? Well, if you are new to this whole thing, we first need a quick crash course in biochemistry and genetics:

Now that you understand genetics, lets learn about epigenetics. Epigenetics, essentially, affects how genes are read by cells, and subsequently how they produce proteins. Here are a few important points about epigenetics:

Heres an analogy that might further help you to understand epigenetics. Think of the human life span as a very long movie. The cells would be the actors and actresses, essential units that make up the movie. DNA, in turn, would be the script instructions for all the participants of the movie to perform their roles. Subsequently, the DNA sequence would be the words on the script, and certain blocks of these words that instruct key actions or events to take place would be the genes. The concept of genetics would be like screenwriting. Follow the analogy so far? Good. The concept ofepigenetics, then, would be like directing. The script can be the same, but the director can choose to eliminate certain scenes or dialogue, altering the movie for better or worse. After all, Steven Spielbergs finished product would be drastically different than Woody Allens forthe same movie script, wouldnt it?

* Editors Note: Be wary of self-help claims that exploit epigenetics and seem too good to be true. We recommend you read about the abuseof epigenetics and pseudoscience.

Ready to learn epigenetics in further detail? Read on:Fundamentals of Epigenetics

Read more here:
A Super Brief and Basic Explanation of Epigenetics for ...

Posted in Epigenetics | Comments Off on A Super Brief and Basic Explanation of Epigenetics for …

Epigenetics and Cancer 2017 | Epigenetics Conferences …

Posted: August 8, 2017 at 6:41 pm

Sessions & Tracks

Track 1 : Cancer

Canceris an abnormal growth of cells which have a tendency to multiply in an uncontrolled way. They have a property to metastasize. The branch of medicine that deals with the prevention, diagnosis and treatment of Cancer is called Oncology.

RelatedOncology Conferences|Cancer Conferences|Cancer meetings

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 2 : Types of Cancer

Cancers are classified and named depending upon the type of cell they originated and have different forms. Some examples are as follows:

RelatedCancer meetings |Oncology Conferences|Cancer Conferences

9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; 16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 3 : Cancer Genetics

Certain changes to genes can alter and control the functioning of the body cells, their growth and division. This causesCancer.

Cancercausing genetic changes :

RelatedCancer Conferences|Cancer meetings|Oncology Conferences

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 4 : Cancer : Diagnostics and Staging

Canceris suspected in a view of a persons symptoms ,screening tests. Affirmation thatCanceris present requires diagnostic tests which is followed by staging. Staging is way of analysing the tumor, its size, location and the treatment depending on theCancerstage.It helps to determine the Prognosis of the patient i,e treatment prediction ,disease outcome and patients recovery chances.

RelatedCancer Conferences|Cancer meetings|Oncology Conferences

9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; 16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 5 : Cancer: Treatment and Therapy

There are many sorts ofCancertreatment. The treatment varies depending on the type of Cancer and its stage.The following are the main types ofCancertreatment :

Related Oncology Conferences|Cancer Conferences|Cancer meetings

InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK;16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA;.

Track 6 : Cancer Stem Cells

Cancer Stem Cells areCancercells present in the tumors. They possess the normal stem cells characteristics i,e their ability to proliferate into different cell types by differentiation.Cancer stem cells are tumorigenic and develops tumors. They also lead to metastasis and relapse thus giving rise to the formation of new tumor cells.Hence there is a need to develop specific therapies targeted at Cancer stem cells to increase the chances of survival of Cancer patients.

Related Cancer Conferences|Cancer meetings|Oncology Conferences

Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK;16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain;

Track 7 : Cancer Epigenetics

The study of epigenetic modifications to theCancercells genome is calledCancer Epigenetics, that does not bring a change in the nucleotide sequence. Risk expectation and prediction andCancerprevention, growth counteractive action are also promising and encouraging areas of Epigenetics.A high adequacy of demethylating agents were accounted for essentially in hematological malignancies in view of new conventions with low dose and long exposure, and their utilization is presently being striven for strong tumors.

During the cellstransformation to Cancerous cell, Epigenetic modifications are also mor important like genetic mutations. Their manipulation brings a great promising approach to for preventing , detecting and therapy of Cancer.

RelatedOncology Conferences|Cancer Conferences|Cancer meetings

19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France;16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 8 : Epigenetics

Epigeneticsdeals with the study of heritable changes in gene , that does not include changes to the basic DNA arrangement an adjustment in phenotype without an adjustment in genotype which influences how cells read the genes.Epigeneticschange is a normal, natural and characteristic occurence yet can likewise be affected by a few factors including age, the environment/lifestyle, and illness state. Epigeneticsmodifications can show as normally as the way in which cells terminally separate to differentiate as liver cells, skin cells, etc.Alternately, epigenetic change can have all the more harming impacts that can bring illnesses, disease.

example :Cancer.

RelatedCancer Conferences|Cancer meetings|Oncology Conferences

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 9 : Developmental and Nutritional Epigenetics

Epigeneticfactors are also called as epigenetic marks control many functions of cells in our bodies. From time to time,Epigeneticmarks cause certain genes to be turned on or off at various phases of the body's development and growth in a way that prompts to a disease onset

In this way, researchers and scientists have been able to find the thin line which is connecting the following diseases to Epigenetics

This track also deals with the modifications and changes that greatly affects the processes such as DNA methylation and histone modifications like embryonic development, aging, and carcinogenesis

Epigenetics plays a key role in wide range of diseases like type 2 Diabetes Mellitus, Obesity, inflammation, and neurocognitive disorders. Nutritional Epigenetics can be considered as an attractive tool to anticipate and prevent Cancer and pediatric developmental diseases

Related Cancer Conferences|Cancer meetings|Oncology Conferences

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 10 : Transgenerational Epigenetic inheritance

Transgenerational epigenetic inheritance is the transmittance of information from one generation to another ,for example :from a parent to child.This affects the offspringstraits without changing the primary structure of DNA.In multicellular organisms the epigenetic inheritance has different mechansisms.

RelatedOncology Conferences|Cancer Conferences|Cancer meetings

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 11 : Epigenetics - Neurodevelopmental and Neurodegenerative disease

Neurodegenerative disorders are among the major difficulties and among the most medical issues that should be withstanded by the world, particularly in light of expanding population age. They cause the degeneration and death of nerve cells as they form incurable conditions for treatment. According to a collaborative study of the WHO, the World Bank and the Harvard School of Public Health by 2020 neurodegenerative diseases,dementia will be the eighth cause of disease among developed regions.It is also estimated that they will occupy the worlds second leading cause of death by 2050, overtaking Cancer During embryogenesis and for differentiation of neural cells Epigenetic mechanisms are essential required. Thus, precise understanding of epigenetic mechanisms, including DNA methylation and histone modification, is important to elucidate the pathogenic pathways in neurodevelopmental disorders

Most common neurodegenerative diseases

RelatedCancer meetings|Oncology Conferences|Cancer Conferences

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 12 : Epigenetic Diseases, Clinical Applications , Pharmacogenomics

This particular track deals with the onset of diseases and the required clinical applications and theraphy related to those diseases.

Pharmacogenomics is a combination of pharmacology and genomics.this branch of study is concerned with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacodynamics and pharmacokinetics. The genetic disorder occurrence is quite rare in polutaion.Some might be hereditary while the others are caused by mutations.

RelatedCancer meetings|Oncology Conferences|Cancer Conferences

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 13 : Biomarkers and Bioinformatics Development in Epigenetics

Histones and DNA are chemically altered with epigenetic markers. They influence chromatin structure by changing the electrostatic nature of the chromatin or by altering the affinity of chromatin-binding proteins. DNA can be modified by methylation of cytosine bases

This track also deals with Bioinformatics role inEpigenetics.This branch is expected to make significant contributions to Epigenetics research. Studies in computational Epigeneticsinvolves the improvement and utilization of bioinformatics strategies for resolving the epigenetic questions, and in addition computational information examination and hypothetical displaying with regards to Epigenetics. This incorporates the effects of histone and DNA CpG island methylation.

Related Oncology Conferences|Cancer Conferences|Cancer meetings

15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK; 16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan.

Track 14 : Epigenomic Effects of Environmental Exposures

Environmental contaminants and toxicants are far reaching all through the world, and can incorporate different materials and chemicals, from by results of ignition to contaminationg trace metals and organic natural mixes utilized as a part of day by day life. Presentation to changing sums and sorts of these contaminants is connected to impacts on human wellbeing .The fields of natural wellbeing and toxicology have concentrated on bettering the comprehension of how these contaminants affect biological prcocesses so that their wellbeing effects can be lessened or anticipated.

Numerous diseases are brought about by various types of alterations among dfifferent genes. Some of these progressions are hereditary changes that are passed along in families while some are mutations that happen due various hazardous environmental factors .

RelatedOncology Conferences|Cancer Conferences|Cancer meetings

16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan; 15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK.

Track 15 : World Cancer Market

Oncology Market is increasing and will be paced on a wide scale.The world wide oncology market is expected to grow in upcoming years due to expanded industry R&D and high investments by multinational companies in the Cancer research.

Related Oncology Conferences|Cancer Conferences|Cancer meetings

15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK; 16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan.

Track 16 : Entreprenuers Investment Meet

A stage planned to associate Entrepreneurs, Proposers and the Investors around the world. It's expected to make and encourage the most streamlined and reasonable meeting place for drawing in individuals in worldwide business disdcussions, assessment and execution of promising business thoughts. A financial specialist might discover the most astounding potential venture openings all around, which give great quantifiable profit. For business visionaries, this would be a perfect place to discover appropriate speculators and accomplices to begin or potentially extend their business. Hence it is an impeccable place to associate Entrepreneurs, Business Owners, Early Stage Companies and Established Corporates with National or International Investors, Corporate Investors and Potential Business Partners.

Related|Oncology Conferences|Cancer Conferences|Cancer meetings

15th WorldCongress on Cancer Therapy(977th Annual Conference) December 05-07, 2016 Philadelphia, Pennsylvania, USA; 8th International Clinical Research andBiomarkers Conference, December 05-07, 2016 Philadelphia, Pennsylvania, USA; InternationalConference on Epigenetics2017, November 13-15, 2017 Frankfurt, Germany; 19thWorld Cancer Conference, Nov 21-23, 2017 London, UK; 11th InternationalConference on Leukemiaand Hematologic Oncology December 04-05, 2017 Madrid, Spain; Medical ExpoCongress on Cancer Drugsand Therapeutics, Sep 11-13, 2017 Paris, France; Global Expertsmeeting on OncologyCase Reports Aug 29-31, 2017 London, UK; 2ndCancer Diagnostics Conference& Expo, May 8-10, 2017 Barcelona, Spain; 9th InternationalConference Cancer BiomarkersAugust 23-24, 2017 Birmingham, UK; 16th Global AnnualOncologistsMeeting, April 24-25, 2017 Dubai, UAE; Global Summit onOncology & Cancer, May 25-27, 2017 Osaka, Japan,; InternationalConference on Cancer Diagnostics, November 27- 28, 2017 Dubai, UAE;9th InternationalCancer Biomarkers Conference, August 07-09, 2017 Osaka, Japan.

In the last few years, the market forCancerprofiling in Asia-Pacific region has seen huge development as a result of increasing incidence ofCancer, high demand for better healthcare services .

High prevalence ofCancer; expanding R&D subsidizing; expanding power of research exercises; expanding application for non-oncology illnesses; and developing organization between scholarly, biotechnology and pharmaceutical organizations are driving components of theCancergenomics and epigenetics market

CancerProfiling Market is divided by Application ,Diagnosis, Technique, Technology etc.

ByApplicationit consists of :

Diagnostic,

Personalized Medicine,

Research.

By Technique, it consists of :

Genomics,

Proteomics,

Metabolomics,

Epigenetics.

By Technology, it consists of :

It is estimated that the worldwide Cancer Profiling business sector is ready to achieve USD 61.87 Billion by 2021 from USD 25.82 Billion in 2016 according to the "Cancer Profiling Market".The following graph depicts the data pictorially.

Central point powering market development are increasing number of malignancy cases over the globe.

Components, for example, the expanding interest for personalized medicine and point-of-care diagnostic tests inCancerprofiling are required to offer an extensive variety of development open doors for players in the tumor profiling market. The personalized medicine segment to represent the biggest share of the worldwide cancer profiling application showcase in 2016.

Across the board continuous research in the part ofEpigeneticsin diseases and disorders in humans is fuelling the worldwide epigenetics drugs, diagnostic technologies and indicative advances.

In light of research territories, the market for Epigenetics is fragmented into developmental biology, drug discovery, oncology and other research areas. Other research areas include genome-wide regulatory mechanisms and research related to several metabolic and genetic diseases.

In light of geology, the market of Epigenetics is divided into North America, Europe, Asia, and the Rest of the World. North America is further sub-segmented into U.S. furthermore, Canada. In Asia, the degree for this present market's development is extending quickly. Asia represents about a large portion of all cancer cases analyzed around the world. This makes helpful conditions for the development of the Epigenetic medications and diagnostics advertise in Asian nations, particularly China, Japan, Australia, and South Korea, with Japan in theprevailing position.

As per the National Cancer Institute, malignancy is among the main sources of death around the world, for which according to a recent review, epigenetic inhibitors comprise of the attributes and capacities which have the potential in cancer prevention and control. This element has given an impulse to the examination directed on epigenetics in the oncology business

In the estimated period between 2015 to 2020 the Epigenetics market is relied upon to stay as the quantity of new participants in this market will continue ascending with the consistent appearance of new innovations combined with upgraded highlights.

See original here:
Epigenetics and Cancer 2017 | Epigenetics Conferences ...

Posted in Epigenetics | Comments Off on Epigenetics and Cancer 2017 | Epigenetics Conferences …

Epigenetics 2017 | Epigenetics | Epigenetics Conference | CME …

Posted: August 8, 2017 at 6:41 pm

Session/ Tracks

Conference series LLC invites all the participants and attendees from all over the world to attendThe 2nd International Congress onEpigenetics & ChromatinduringNovember 06 - 08, 2017which is the only bench to bedside review of the drug discovery and development process.

The live format of this educational activity will be accredited with CME and CPD Credits

It will help scientific leaders from academia, pharma and biotech drive advances in novel epigenetic based therapeutics through the latest updates in pre-clinical and clinical translational research from oncology to new exciting disease areas.

Join us inFrankfurt, Germanyto delve deeper into mechanistic understanding, lead compound discovery and development, and methods for forging and promoting collaboration to achieve the translational progression of the next wave of epigenetic therapeutics.

Attendance at this meeting will enable you to:

Be part of a rich scientific programme incorporating the latest developments in preclinicalGenetic Disorders

Understand the shift towards prevention and early diagnosis ofGenetic Disordersas the future of research in the field

Join key opinion leaders in discussing regulatory and ethical implications of this research in clinical practice.

Network with speakers and other leading experts across disciplines.

Track 1.Epigenetics

Epigeneticsrefers to heritable changes in gene expression that occur without alteration in DNA sequence. These changes may be induced spontaneously, induced by environmental factors or as a consequence of specific mutations. There are two primary and interconnected epigenetic mechanisms:DNA methylationand covalent modification of histones.

RelatedGenetics Conferences|Epigenetics Conferences|Molecular Biology Conferences| Cancer Conference

World Congress onHuman GeneticsNovember 07- 08, 2016 Barcelona, Spain; 12th EuroBiotechnologyCongress November 7-9, 2016 Alicante, Spain; 13thBiotechnologyCongress November 28-30, 2016 San Francisco, USA; Global Congress onTissue Engineering and Regenerative MedicineDecember 01-02, 2016 San Antonio, USA; International Conference on Clinical andMedical GeneticsDecember 01-02, 2016 Atlanta, USA; International Conference onGenetic CounsellingandGenomic MedicineDecember 07-08, 2016 Madrid, Spain; 8th World Congress and Expo on Cell &Stem Cell ResearchMarch 20-22, 2017 Orlando, Florida, USA; 7th International Conference onPlant GenomicsJuly 03-05, 2017 Bangkok, Thailand; 3rd International Conference on Systems andSynthetic BiologyJuly 20-21, 2017 Munich, Germany; 3rd International Conference & Exhibition onTissue PreservationandBio bankingAugust 23-24, 2017 San Francisco, USA

RelatedEpigenetics Societies|Genetics Societies|Cancer Societies

ClinicalEpigeneticsSociety,GeneticsSociety of America, The American Society ofHuman Genetics, National Society ofGenetic Counselors, BehaviorGeneticsAssociation, Association forClinical GeneticScience, Association ofGenetic Technologists, Genetics Society of America, American College ofMedical Genetics, American Board of Medical Genetics, American Board of Genetic Counsellors, Association of Professors of Human and Medical Genetics, International Federation of HumanGeneticsSocieties, InternationalGenetic EpidemiologySociety, International Genetics Education Network, The Jackson Laboratory, National Society of Genetic Counsellors, TheHuman GenomeOrganization

Track 2.Epigenomics

Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous togenomicsand proteomics, which are the study of the genome and proteome of a cell. Epigenetic modifications are reversible modifications on a cells DNA or histones that affect gene expression without altering the DNA sequence.

RelatedGenetics Conferences|Epigenetics Conferences|Molecular Biology Conferences|Cancer Conference

World Congress onHuman GeneticsNovember 07- 08, 2016 Barcelona, Spain; 12th EuroBiotechnologyCongress November 7-9, 2016 Alicante, Spain; 13thBiotechnologyCongress November 28-30, 2016 San Francisco, USA; Global Congress onTissue Engineering and Regenerative MedicineDecember 01-02, 2016 San Antonio, USA; International Conference on Clinical andMedical GeneticsDecember 01-02, 2016 Atlanta, USA; International Conference onGenetic CounsellingandGenomic MedicineDecember 07-08, 2016 Madrid, Spain; 8th World Congress and Expo on Cell &Stem Cell ResearchMarch 20-22, 2017 Orlando, Florida, USA; 7th International Conference onPlant GenomicsJuly 03-05, 2017 Bangkok, Thailand; 3rd International Conference on Systems andSynthetic BiologyJuly 20-21, 2017 Munich, Germany; 3rd International Conference & Exhibition onTissue PreservationandBio bankingAugust 23-24, 2017 San Francisco, USA

RelatedEpigenetics Societies|Genetics Societies|Cancer Societies

ClinicalEpigeneticsSociety,GeneticsSociety of America, The American Society ofHuman Genetics, National Society ofGenetic Counselors, BehaviorGeneticsAssociation, Association forClinical GeneticScience, Association ofGenetic Technologists, Genetics Society of America, American College ofMedical Genetics, American Board of Medical Genetics, American Board of Genetic Counsellors, Association of Professors of Human and Medical Genetics, International Federation of HumanGeneticsSocieties, InternationalGenetic EpidemiologySociety, International Genetics Education Network, The Jackson Laboratory, National Society of Genetic Counsellors, TheHuman GenomeOrganization

Track 3.Immunogenetics

Immunogeneticsorimmungeneticsis the branch of medical research that explores the relationship between the immune system and genetics. Autoimmune diseases, such as type 1 diabetes, are complex genetic traits which result from defects in the immune system.

RelatedGenetics Conferences|Epigenetics Conferences|Molecular Biology Conferences|Cancer Conference

World Congress onHuman GeneticsNovember 07- 08, 2016 Barcelona, Spain; 12th EuroBiotechnologyCongress November 7-9, 2016 Alicante, Spain; 13thBiotechnologyCongress November 28-30, 2016 San Francisco, USA; Global Congress onTissue Engineering and Regenerative MedicineDecember 01-02, 2016 San Antonio, USA; International Conference on Clinical andMedical GeneticsDecember 01-02, 2016 Atlanta, USA; International Conference onGenetic CounsellingandGenomic MedicineDecember 07-08, 2016 Madrid, Spain; 8th World Congress and Expo on Cell &Stem Cell ResearchMarch 20-22, 2017 Orlando, Florida, USA; 7th International Conference onPlant GenomicsJuly 03-05, 2017 Bangkok, Thailand; 3rd International Conference on Systems andSynthetic BiologyJuly 20-21, 2017 Munich, Germany; 3rd International Conference & Exhibition onTissue PreservationandBio bankingAugust 23-24, 2017 San Francisco, USA

RelatedEpigenetics Societies|Genetics Societies|Cancer Societies

ClinicalEpigeneticsSociety,GeneticsSociety of America, The American Society ofHuman Genetics, National Society ofGenetic Counselors, BehaviorGeneticsAssociation, Association forClinical GeneticScience, Association ofGenetic Technologists, Genetics Society of America, American College ofMedical Genetics, American Board of Medical Genetics, American Board of Genetic Counsellors, Association of Professors of Human and Medical Genetics, International Federation of HumanGeneticsSocieties, InternationalGenetic EpidemiologySociety, International Genetics Education Network, The Jackson Laboratory, National Society of Genetic Counsellors, TheHuman GenomeOrganization

Track 4.Translational Epigenetics

Cancer epigenetics research is now entering an exciting phase of translationalepigeneticswhereby novel epigenome therapeutics is being developed for application in clinical settings. Epigenetics refers to all heritable and potentially reversible changes in gene or genome functioning that occurs without altering the nucleotide sequence of the DNA. A range of different epigenetic "marks" can activate or repress gene expression.

RelatedGenetics Conferences|Epigenetics Conferences|Molecular Biology Conferences|Cancer Conference

World Congress onHuman GeneticsNovember 07- 08, 2016 Barcelona, Spain; 12th EuroBiotechnologyCongress November 7-9, 2016 Alicante, Spain; 13thBiotechnologyCongress November 28-30, 2016 San Francisco, USA; Global Congress onTissue Engineering and Regenerative MedicineDecember 01-02, 2016 San Antonio, USA; International Conference on Clinical andMedical GeneticsDecember 01-02, 2016 Atlanta, USA; International Conference onGenetic CounsellingandGenomic MedicineDecember 07-08, 2016 Madrid, Spain; 8th World Congress and Expo on Cell &Stem Cell ResearchMarch 20-22, 2017 Orlando, Florida, USA; 7th International Conference onPlant GenomicsJuly 03-05, 2017 Bangkok, Thailand; 3rd International Conference on Systems andSynthetic BiologyJuly 20-21, 2017 Munich, Germany; 3rd International Conference & Exhibition onTissue PreservationandBio bankingAugust 23-24, 2017 San Francisco, USA

RelatedEpigenetics Societies|Genetics Societies|Cancer Societies

ClinicalEpigeneticsSociety,GeneticsSociety of America, The American Society ofHuman Genetics, National Society ofGenetic Counselors, BehaviorGeneticsAssociation, Association forClinical GeneticScience, Association ofGenetic Technologists, Genetics Society of America, American College ofMedical Genetics, American Board of Medical Genetics, American Board of Genetic Counsellors, Association of Professors of Human and Medical Genetics, International Federation of HumanGeneticsSocieties, InternationalGenetic EpidemiologySociety, International Genetics Education Network, The Jackson Laboratory, National Society of Genetic Counsellors, TheHuman GenomeOrganization

Track 5.Neurodevelopmental disorders

Epigenetic modifications such as methylation of CpGs (a dinucleotide composed of a 2'-deoxycytosine and a 2' deoxyguanosine) and histone tail modifications allow activation or repression of certain genes within a cell, in order to create cell memory either in favor of using a gene or not using a gene. These modifications can either originate from the parental DNA, or can be added to the gene by various proteins and can contribute to differentiation.

RelatedGenetics Conferences|Epigenetics Conferences|Molecular Biology Conferences|Cancer Conference

World Congress onHuman GeneticsNovember 07- 08, 2016 Barcelona, Spain; 12th EuroBiotechnologyCongress November 7-9, 2016 Alicante, Spain; 13thBiotechnologyCongress November 28-30, 2016 San Francisco, USA; Global Congress onTissue Engineering and Regenerative MedicineDecember 01-02, 2016 San Antonio, USA; International Conference on Clinical andMedical GeneticsDecember 01-02, 2016 Atlanta, USA; International Conference onGenetic CounsellingandGenomic MedicineDecember 07-08, 2016 Madrid, Spain; 8th World Congress and Expo on Cell &Stem Cell ResearchMarch 20-22, 2017 Orlando, Florida, USA; 7th International Conference onPlant GenomicsJuly 03-05, 2017 Bangkok, Thailand; 3rd International Conference on Systems andSynthetic BiologyJuly 20-21, 2017 Munich, Germany; 3rd International Conference & Exhibition onTissue PreservationandBio bankingAugust 23-24, 2017 San Francisco, USA

RelatedEpigenetics Societies|Genetics Societies|Cancer Societies

ClinicalEpigeneticsSociety,GeneticsSociety of America, The American Society ofHuman Genetics, National Society ofGenetic Counselors, BehaviorGeneticsAssociation, Association forClinical GeneticScience, Association ofGenetic Technologists, Genetics Society of America, American College ofMedical Genetics, American Board of Medical Genetics, American Board of Genetic Counsellors, Association of Professors of Human and Medical Genetics, International Federation of HumanGeneticsSocieties, InternationalGenetic EpidemiologySociety, International Genetics Education Network, The Jackson Laboratory, National Society of Genetic Counsellors, TheHuman GenomeOrganization

Track 6.Bioinformatics Development in Epigenetics

Research in computational epigenetics comprises the development and application ofbioinformaticsmethods for solving epigenetic questions, as well as computational data analysis and theoretical modeling in the context of epigenetics. This includes modelling of the effects of histone and DNA CpG island methylation.

RelatedGenetics Conferences|Epigenetics Conferences|Molecular Biology Conferences|Cancer Conference

World Congress onHuman GeneticsNovember 07- 08, 2016 Barcelona, Spain; 12th EuroBiotechnologyCongress November 7-9, 2016 Alicante, Spain; 13thBiotechnologyCongress November 28-30, 2016 San Francisco, USA; Global Congress onTissue Engineering and Regenerative MedicineDecember 01-02, 2016 San Antonio, USA; International Conference on Clinical andMedical GeneticsDecember 01-02, 2016 Atlanta, USA; International Conference onGenetic CounsellingandGenomic MedicineDecember 07-08, 2016 Madrid, Spain; 8th World Congress and Expo on Cell &Stem Cell ResearchMarch 20-22, 2017 Orlando, Florida, USA; 7th International Conference onPlant GenomicsJuly 03-05, 2017 Bangkok, Thailand; 3rd International Conference on Systems andSynthetic BiologyJuly 20-21, 2017 Munich, Germany; 3rd International Conference & Exhibition onTissue PreservationandBio bankingAugust 23-24, 2017 San Francisco, USA

RelatedEpigenetics Societies|Genetics Societies|Cancer Societies

ClinicalEpigeneticsSociety,GeneticsSociety of America, The American Society ofHuman Genetics, National Society ofGenetic Counselors, BehaviorGeneticsAssociation, Association forClinical GeneticScience, Association ofGenetic Technologists, Genetics Society of America, American College ofMedical Genetics, American Board of Medical Genetics, American Board of Genetic Counsellors, Association of Professors of Human and Medical Genetics, International Federation of HumanGeneticsSocieties, InternationalGenetic EpidemiologySociety, International Genetics Education Network, The Jackson Laboratory, National Society of Genetic Counsellors, TheHuman GenomeOrganization

Track 7.Epigenomic Effects of Environmental Exposures

Environmental contaminants and toxicants are widespread throughout the world, and can include various materials and chemicals, from by products of combustion to contaminating trace metals and residual organic compounds used in daily life. Exposure to varying amounts and types of these contaminants is linked to impacts on human health and the fields ofenvironmentalhealth and toxicology have focused on bettering the understanding of how these contaminants impact biological processes so that their health impacts can be attenuated or prevented.

RelatedGenetics Conferences|Epigenetics Conferences|Molecular Biology Conferences|Cancer Conference

World Congress onHuman GeneticsNovember 07- 08, 2016 Barcelona, Spain; 12th EuroBiotechnologyCongress November 7-9, 2016 Alicante, Spain; 13thBiotechnologyCongress November 28-30, 2016 San Francisco, USA; Global Congress onTissue Engineering and Regenerative MedicineDecember 01-02, 2016 San Antonio, USA; International Conference on Clinical andMedical GeneticsDecember 01-02, 2016 Atlanta, USA; International Conference onGenetic CounsellingandGenomic MedicineDecember 07-08, 2016 Madrid, Spain; 8th World Congress and Expo on Cell &Stem Cell ResearchMarch 20-22, 2017 Orlando, Florida, USA; 7th International Conference onPlant GenomicsJuly 03-05, 2017 Bangkok, Thailand; 3rd International Conference on Systems andSynthetic BiologyJuly 20-21, 2017 Munich, Germany; 3rd International Conference & Exhibition onTissue PreservationandBio bankingAugust 23-24, 2017 San Francisco, USA

RelatedEpigenetics Societies|Genetics Societies|Cancer Societies

ClinicalEpigeneticsSociety,GeneticsSociety of America, The American Society ofHuman Genetics, National Society ofGenetic Counselors, BehaviorGeneticsAssociation, Association forClinical GeneticScience, Association ofGenetic Technologists, Genetics Society of America, American College ofMedical Genetics, American Board of Medical Genetics, American Board of Genetic Counsellors, Association of Professors of Human and Medical Genetics, International Federation of HumanGeneticsSocieties, InternationalGenetic EpidemiologySociety, International Genetics Education Network, The Jackson Laboratory, National Society of Genetic Counsellors, TheHuman GenomeOrganization

Track 8.Epigenetic Diseases Clinical Applications

Epigenetic changes potentially useful as tumor markers are now under clinical trials, and useful markers will be selected. Risk prediction and cancer prevention are also promising areas ofepigenetics. A high efficacy of demethylating agents was reported mainly in hematological malignancies based on new protocols (lower dose and/or longer exposure), and their use is now being tried for solid tumors.

RelatedGenetics Conferences|Epigenetics Conferences|Molecular Biology Conferences|Cancer Conference

World Congress onHuman GeneticsNovember 07- 08, 2016 Barcelona, Spain; 12th EuroBiotechnologyCongress November 7-9, 2016 Alicante, Spain; 13thBiotechnologyCongress November 28-30, 2016 San Francisco, USA; Global Congress onTissue Engineering and Regenerative MedicineDecember 01-02, 2016 San Antonio, USA; International Conference on Clinical andMedical GeneticsDecember 01-02, 2016 Atlanta, USA; International Conference onGenetic CounsellingandGenomic MedicineDecember 07-08, 2016 Madrid, Spain; 8th World Congress and Expo on Cell &Stem Cell ResearchMarch 20-22, 2017 Orlando, Florida, USA; 7th International Conference onPlant GenomicsJuly 03-05, 2017 Bangkok, Thailand; 3rd International Conference on Systems andSynthetic BiologyJuly 20-21, 2017 Munich, Germany; 3rd International Conference & Exhibition onTissue PreservationandBio bankingAugust 23-24, 2017 San Francisco, USA

RelatedEpigenetics Societies|Genetics Societies|Cancer Societies

ClinicalEpigeneticsSociety,GeneticsSociety of America, The American Society ofHuman Genetics, National Society ofGenetic Counselors, BehaviorGeneticsAssociation, Association forClinical GeneticScience, Association ofGenetic Technologists, Genetics Society of America, American College ofMedical Genetics, American Board of Medical Genetics, American Board of Genetic Counsellors, Association of Professors of Human and Medical Genetics, International Federation of HumanGeneticsSocieties, InternationalGenetic EpidemiologySociety, International Genetics Education Network, The Jackson Laboratory, National Society of Genetic Counsellors, TheHuman GenomeOrganization

Track 9.Pharmacogenomics & Personalized Medicine

Pharmacogenomics is the study of the role of the genome in drug response. Its name (pharmaco- + genomics) reflects its combining ofpharmacologyand genomics. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms withpharmacokineticsand pharmacodynamics (drug absorption, distribution, metabolism, and elimination), as well as drug receptor target effects.

RelatedGenetics Conferences|Epigenetics Conferences|Molecular Biology Conferences|Cancer Conference

World Congress onHuman GeneticsNovember 07- 08, 2016 Barcelona, Spain; 12th EuroBiotechnologyCongress November 7-9, 2016 Alicante, Spain; 13thBiotechnologyCongress November 28-30, 2016 San Francisco, USA; Global Congress onTissue Engineering and Regenerative MedicineDecember 01-02, 2016 San Antonio, USA; International Conference on Clinical andMedical GeneticsDecember 01-02, 2016 Atlanta, USA; International Conference onGenetic CounsellingandGenomic MedicineDecember 07-08, 2016 Madrid, Spain; 8th World Congress and Expo on Cell &Stem Cell ResearchMarch 20-22, 2017 Orlando, Florida, USA; 7th International Conference onPlant GenomicsJuly 03-05, 2017 Bangkok, Thailand; 3rd International Conference on Systems andSynthetic BiologyJuly 20-21, 2017 Munich, Germany; 3rd International Conference & Exhibition onTissue PreservationandBio bankingAugust 23-24, 2017 San Francisco, USA

RelatedEpigenetics Societies|Genetics Societies|Cancer Societies

ClinicalEpigeneticsSociety,GeneticsSociety of America, The American Society ofHuman Genetics, National Society ofGenetic Counselors, BehaviorGeneticsAssociation, Association forClinical GeneticScience, Association ofGenetic Technologists, Genetics Society of America, American College ofMedical Genetics, American Board of Medical Genetics, American Board of Genetic Counsellors, Association of Professors of Human and Medical Genetics, International Federation of HumanGeneticsSocieties, InternationalGenetic EpidemiologySociety, International Genetics Education Network, The Jackson Laboratory, National Society of Genetic Counsellors, TheHuman GenomeOrganization

Track 10.Genetic disorders

A genetic disorder is a genetic problem caused by one or more abnormalities in the genome, especially a condition that is present from birth (congenital). Mostgenetic disordersare quite rare and affect one person in every several thousands or millions. Genetic disorders may be hereditary, passed down from the parents' genes. In other genetic disorders, defects may be caused by new mutations or changes to the DNA. In such cases, the defect will only be passed down if it occurs in the germ line.

RelatedGenetics Conferences|Epigenetics Conferences|Molecular Biology Conferences|Cancer Conference

World Congress onHuman GeneticsNovember 07- 08, 2016 Barcelona, Spain; 12th EuroBiotechnologyCongress November 7-9, 2016 Alicante, Spain; 13thBiotechnologyCongress November 28-30, 2016 San Francisco, USA; Global Congress onTissue Engineering and Regenerative MedicineDecember 01-02, 2016 San Antonio, USA; International Conference on Clinical andMedical GeneticsDecember 01-02, 2016 Atlanta, USA; International Conference onGenetic CounsellingandGenomic MedicineDecember 07-08, 2016 Madrid, Spain; 8th World Congress and Expo on Cell &Stem Cell ResearchMarch 20-22, 2017 Orlando, Florida, USA; 7th International Conference onPlant GenomicsJuly 03-05, 2017 Bangkok, Thailand; 3rd International Conference on Systems andSynthetic BiologyJuly 20-21, 2017 Munich, Germany; 3rd International Conference & Exhibition onTissue PreservationandBio bankingAugust 23-24, 2017 San Francisco, USA

RelatedEpigenetics Societies|Genetics Societies|Cancer Societies

ClinicalEpigeneticsSociety,GeneticsSociety of America, The American Society ofHuman Genetics, National Society ofGenetic Counselors, BehaviorGeneticsAssociation, Association forClinical GeneticScience, Association ofGenetic Technologists, Genetics Society of America, American College ofMedical Genetics, American Board of Medical Genetics, American Board of Genetic Counsellors, Association of Professors of Human and Medical Genetics, International Federation of HumanGeneticsSocieties, InternationalGenetic EpidemiologySociety, International Genetics Education Network, The Jackson Laboratory, National Society of Genetic Counsellors, TheHuman GenomeOrganization

Live format of the conference is accredited with CME and CPD Credits

Conference series LLC invites all the participants and attendees from all over the world to attend International Conference onEpigenetics 2017duringNovember 06 - 08, 2017atFrankfurt, Germanywith the Theme:Revolutionary Strategies in Diagnosis and Treatment of Cancer and Genetic Disorderswhich includes prompt Keynote Presentations, Oral talks, Poster Presentations, Workshop, Symposia and Exhibitions.

This activity has been planned and implemented in accordance with the accreditation requirements and policies of theAccreditation Council forContinuing Medical Education(ACCME) through the joint providership of PeerPoint Medical Education Institute and Conference Series, LLC.PeerPoint Medical Education Institute is accredited by the ACCME to provide continuing medical education for physicians.

PeerPoint Medical Education Institute designates the live format for this educational activity forAMA PRA Category 1 Credits.Physicians should only claim credit commensurate with the extent of their participation in the activity.

Benefits of attending the conference:

Understanding the importance of studying purified cellepigenomes

Envisioning how single nucleotide polymorphisms (SNPs) can affectepigeneticregulation

Learning about useful resources forepigenomicdata mining

Obtaining an overview of the steps towards identifying functional SNPs

The important target of this congress is to give a worldwide gathering to front line research in chromatin andepigenetics. This meeting gives the focal hub for individuals to exhibit their exploration and trade thoughts in an European venue. The sorting out group gathers top speakers covering the most recent advances in the field, fusing assorted qualities in each sense.

The overarching goal of this conference series is to coverchromatin regulation, chromatin dynamics, signalling to chromatin, nuclear architecture and dynamics, developmental epigenetics,epigenomics, epigenetics and human diseases, genome stability,environmental epigenetics, and Trans generational inheritance. We also include talks on latest approaches for studying these biological questions, including functional genomics,system biologyand super resolution microscopy.

Glance at the Market

Theepigeneticsbusiness sector is relied upon to achieve USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64%. Epigenetics is characterized as the investigation of the heritable changes in quality expression, with no progressions to the primary DNA arrangement. At the end of the day, epigenetics alludes to covalent change of DNA, RNA, or protein.

High predominance of growth; expanding R and D financing; expanding force of examination exercises; expanding application for non-oncology sicknesses; and developing association between scholarly, biotechnology and pharmaceutical organizations are driving components of theepigeneticsmarket.

Why to attend?

EpigeneticsConference is a novel discussion to unite overall recognized scholastics in the field of Genetics,Genomicsand Proteomics Researchers, Public wellbeing experts, Scientists, Academic researchers, Industry specialists, Scholars to trade about condition of the Research and Development.

Point of this gathering is to fortify new views for treatment that will be valuable over the range of Epigenetics. A Unique Opportunity for Advertisers and Sponsors at this International occasion.

Target Audience

Business delegates, Industrial Leaders, Drug Discovery/Development Scientists, Molecular Biologists, Principal Investigators, Cell Biologists, CEO's and R&D Heads from Industries, Directors, Head of office, Professors and Students from Academia in the exploration of Genetics.

Our Conference will give an impeccable stage tending to:

Laudable talks by the choice of the worldwide academic group

Sterling workshop sessions

Remarkable Awards and Global Recognition to worthy Researchers

Global Networking with 50+ Countries

Novel Techniques to Benefit Your Research

Global Business and Networking Opportunities

Exquisite Platform for showcasing your items and International Sponsorship

Go here to see the original:
Epigenetics 2017 | Epigenetics | Epigenetics Conference | CME ...

Posted in Epigenetics | Comments Off on Epigenetics 2017 | Epigenetics | Epigenetics Conference | CME …

Epigenetics Around the Web: Should farmers use vinegar, instead of genetically engineered solutions, to protect … – Genetic Literacy Project

Posted: August 8, 2017 at 6:41 pm

For five years California was mired in a statewide drought, which ended this past April. Hundreds of thousands of farmland acreage in the state went unplantedbecause there was no easy way to combat the crisis.

But a recent study from researchers at RIKEN Center for Sustainable Resource Science suggest the farmers woes had a simple remedy to the lack of rain, and it could be found in their kitchen cupboards: vinegar. At least thats the way the media reported it. But is that what the research concluded?

The study, published in Nature Plants, investigated the effects of growing Arabidopsis plants (a common model organism for studying crops) in vinegar. The results? Those grown in the common salad-dressing component had greater drought tolerance. Acetate (a central component of vinegar) triggered the activation of an epigenetically regulated biological pathway that, in times of stress, flips the plant from metabolizing sugar to acetate.

Normally, the pathway begins by producing an abundance of acetate, which triggers the metabolic switch from sugar to acetate. Interestingly, under drought conditions the more acetate an Arabidopsis plant produces the more likely it is to survive a drought. This led the RIKEN team to grow the plants in vinegar during a drought. Low and behold, those grown in vinegar survived at a much higher rate than those that werent.

The effect of several organic acids on plant drought tolerance after 14 days. From left to right, water, HCl, formic acid, acetic acid, butyric acid, lactic acid, citric acid. Note, only plants treated with acetic acid survived. Credit: RIKEN

The key finding: this mechanism was conserved in a few staple crops, rice, wheat and corn. Replicating the study with these crops produced similar results to themodel.

So its that easy right? Drought is no longer a concern to farmers? Anytime the weather is expected to hot and dry, farmers could head to the grocery store to stock up on vinegar. Thats the impression readers may have gotten fromsome of the stories covering the study in the science, mainstream and farming press:

Phys.org: Vinegar: A cheap and simple way to help plants fight drought

Popular Science:Growing plants in vinegar could help them survive drought

Modern Farmer: VinegarA New Way for Crops to Fight Drought?

Sacramento Bee: Vinegarcan helpplantssurvive drought

Our **cough** friends at Natural Newsthe quack website promoted by many critics of conventional agriculturehad its own take on the study, twisting the results to take yet another jab at GMOs:

In fact, the studys authors were the ones who first hinted at the idea that vinegar applications to relieve droughtunproven and untestedcould better address crop environmental stresses than advanced conventional breeding or genetic engineering. Study co-leader Jong-Myong Kim said in the press release:

Although transgenic technologies can be used to create plants that are more tolerant to drought, we must also develop simple and less expensive technologies because genetically modified plants are not available in all several countries. We expect that external application ofacetateto plants will be a useful, simple, and less expensive way to enhancedroughttolerance in a variety of plants.

Reality check

Is this really the case? Should we forget about other solutions and focus on what appears to be the easy fix of vinegar? The science says probably not.

I spoke with crop epigeneticist Chad Niederhuth, a postdoctoral research associate at the University of Georgia. Hecautioned that its a big leap from a shortstudy conducted in the kind of rock solid research that can only be achieved by long-term studies in the field. One thing Niederhuth would want to know is to what degree unnaturally priming this pathway might impact crop yields long term. He said it doesnt seem to be the case in their small lab study, but theres no way to know for sure until someone does it.

Nor is there any way to know yet what the effect on the health of the soil and microbiome will be of constantly spraying the land with an acid (vinegar is a solution of acetic acid). Acetic acid is actually more toxic than glyphosate, the current iconic villain of anti-GMO activists.

In the study, the actual discovery was made by mutating an epigenetic enzyme (histone deacetylase 6). I asked Niederhuth if there was any benefit to activating this pathway genetically and he said that priming the stress response with vinegar would likely produce a weaker physiological response than if the genes were altered.

The situation is akin in some ways to that of the Bt insect-resistance trait that is common to many crops (e.g. corn, cotton, eggplant). The Bt protein is an effective natural pesticide. It is derived from a bacterium and is approved in organic agriculture for topical use. But in some areas, farmers have to spray it constantly on their crops throughout the growing season for it to be effective.

For example,eggplant farmers in Bangladesh have to apply it to their fields as frequently as twice a week dozens of times over the course of a growing season to ensure their crops are not devastated by pests. The genetically engineered alternativeinserting the natural bacterium directly into the genomes of cropsallows plants to produce the Bt protein on their own, which drastically reduced the need for pesticide application to as little as once or just a few times a season.

Fewer applications translates to far lower chemical exposure rates for farm workers, many of whom are women and children, and major economic savings. And with the need for fewer passes across the land with the tractor, Bt crops have been a boon for the environment.

Genetic engineering solutions

Considering the reality that the vinegar solution remains unproven, and far into the future if it should indeed pan out, what are nearer term alternatives? A crop that has the gene for histone deacetylase6 altered to trigger the acetate pathway on its own wouldnt require a steady exogenous supply of vinegar. Its not a large leap to predict similar benefits as Bt.

Epigenetically enhanced sorghum epiF2 Tx430 lines have higher yields that control Tx430 lines. Source: Epicrop

Furthermore, it wouldnt necessarily have to be a transgenic crop. Histone deacetylase 6 induces epigenetic changes. So, in theory, these crops could be created by targeting these modifications.

Also, these crops likely wont face the regulatory hurdles others have because they do not involve a change in the gene sequence.

While no epigenetically modified crops exist on the market currently, they are progressing quickly. One company, Epicrop, has had an abundance of success in boosting yields in sorghum by modifying the plants epigenetics.

Actually, despite what the studys authors said, transgenesis (the movement of genes from one species to another) doesnt present any major technical challenges. The study involved a mutation of an already occurring sequence in the Arabidopsis genome, a sequence that is conserved (i.e. the same or very similar) in corn, rice and wheat. The mutation only has to be replicated in those crops in a similar way. In other words, the crop may not have to be a GMO at all.

On the other hand, Niederhuth saidresearch into genes and stress tolerance has faltered in some cases because having a constant stress tolerance mechanismcreates problems of its own. Vinegar application may be a compromise if its used in a targeted way. His main point, and its a good one, was that only time and science will tell. Until the science is clearer, all potential solutions should be pursued.

So, nobody should be stocking up on vinegar in hopes of rescuing a rain-starved cropat least not yet.

Nicholas Staropoli, founding director of the Epigenetics Literacy Project, is a contributing writer and editor. BIO. Follow him on Twitter @NickfrmBoston.

Related Stories

Read this article:
Epigenetics Around the Web: Should farmers use vinegar, instead of genetically engineered solutions, to protect ... - Genetic Literacy Project

Posted in Epigenetics | Comments Off on Epigenetics Around the Web: Should farmers use vinegar, instead of genetically engineered solutions, to protect … – Genetic Literacy Project

Mutation in prostate tumors shown to change epigenetic identity, the … – Medical Xpress

Posted: August 8, 2017 at 6:41 pm

Cancer cell during cell division. Credit: National Institutes of Health

Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples. The discovery also identifies a new opportunity for targeted therapy.

The findings are published online today in Nature Genetics. The research shows how an acquired mutation involving the fusion of two genes (TMPRSS2 and ERG) can change the epigenetic identity of tumours leading to some genes being turned on while others are turned off, says Dr. Mathieu Lupien, corresponding author and Senior Scientist at Princess Margaret Cancer Centre, University Health Network, and a member of its Cancer Epigenetics Program, a team focused on breaking the code of cancer.

The discoveries highlight the power of mutations to influence epigenetics in prostate tumours to change the identity of cancer cells. Dr. Lupien's team exploited this fact to identify mechanisms that drive development of fusion-positive prostate cancer.

"Our findings specifically show that fusion-positive prostate cancer is dependent on the NOTCH signalling pathway, which can be blocked chemically in pre-clinical models," says Dr. Lupien. "This identifies a promising druggable target against fusion-positive prostate cancer and takes us a step closer to providing personalized cancer medicine for up to 50% of prostate cancer patients," he says.

The video will load shortly

"We're hopeful this research can be translated into clinical care in the near future to offer patients an additional, tailored treatment to complement the current standard of care, based on their fusion profile."

The study team consisted of scientists, pathologists and clinician-scientists involved in the Canadian Prostate Cancer Genome Network (CPC-GENE), the world-leading prostate cancer sequencing program co-led by Dr. Robert Bristow at the Princess Margaret Cancer Centre and Dr. Paul Boutros at the Ontario Institute for Cancer Research.

Dr. Lupien is also an Associate Professor in the Department of Biomedical Physics, University of Toronto.

Explore further: Breast cancer researchers look beyond genes to find more drivers of disease development

More information: TMPRSS2ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer, Nature Genetics (2017). DOI: 10.1038/ng.3930

See the original post:
Mutation in prostate tumors shown to change epigenetic identity, the ... - Medical Xpress

Posted in Epigenetics | Comments Off on Mutation in prostate tumors shown to change epigenetic identity, the … – Medical Xpress

Using Epigenetics to Combat a Terrible Neglected Tropical Disease – WhatIsEpigenetics.com

Posted: August 8, 2017 at 6:41 pm

A small freshwater parasite burrows into the bare skin of unbeknownst swimmer and enters their bloodstream. Once inside the blood, it grows into an adult worm, quietly feasting on its victims nutrients and breeding for some time, until one day its destruction becomes serious and life-threatening. While this could be the storyline of a bad horror film, its tragically the real tale of schistosomiasis a deadly neglected tropical disease that kills more than 200,000 people each year in developing countries, predominantly in Africa.

In an effort to understand and control schistosomiasis, health officials around the globe are seeking strategies that target the life cycle of the parasite, ones that can block early development of the organism. Because epigenetics plays a role in host/pathogen co-evolutionary biology, researchers in the UK examined DNA methylation, a common epigenetic signaling tool, with the purpose of revealing key factors associated with this diseases transmission. Their study was recently published in the May issue of PLOS: Neglected Tropical Diseases.

According the World Health Organization (WHO), schistosomiasis is one of the most devastating parasitic diseases on the planet, second only to malaria. Impacting an estimated 218 million people in 78 counties, schistosomiasis is a considered a disease of poverty. This is because the lack of clean water and sanitation in the deprived communities where it is found create the ideal environment for the disease-causing parasite, which is transmitted simply by contact with contaminated water (e.g. wading, swimming, and washing).

Often called bilharziosis or snail fever, schistosomiasis is caused by a trematode flatworm whose larval form is emitted by freshwater snails (Biomphalaria glabrata or B.glabrata). Once in the water, this microscopic organism can easily penetrate the skin of an exposed person. It then matures inside the human hosts blood vessels, where it reproduces and sheds some of its eggs via the bodys urine or feces. When an infected person urinates or defecates in freshwater areas, the eggs migrate back to the snails and the cycle starts all over again. Other eggs can become trapped in body tissues, causing immune reactions and progressive damage to organs. Without treatment, schistosomiasis can persist for years, resulting in long-term ill health and death.

Medical control of the disease relies primarily on the availability of the chemotherapeutic drug praziquantel. However, mass treatment with this drug (as promoted in sub-Saharan Africa) merely increases the possibility of the parasites resistance to it. Chemical and biological eradication of the host snail population has been somewhat successful; however, large-scale efforts to exterminate this species of molluskshave failed. The snails high reproductive rate and temperature tolerance, combined with dam and irrigation construction, have unfortunately expanded the diseases spread to unaffected regions. And, its predicted that global warming will accelerate this spread more northward. Without a preventative vaccine available or access to healthcare, individuals living in and visiting these at-risk areas are susceptible, not only to initial infection, but continuous recurrence. Therefore, it is vital to find alternative methods to control the spread of schistosomiasis.

In the UK study, conducted at Institute of Biological, Environmental and Rural Sciences at Aberystwyth University, the researchers focused on the parasites intermediate host snail stage. They chose to investigate the snails underlying biology and molecular processes, in particular DNA methylation.

While much is known about how the definitive host responds to schistosome infection, they reported, there is comparably less information available describing the snails response to infection. Their aim at studying the snails epigenetic machinery was to gain a better understanding the host-parasite relationship, as well as identify new targets that could be useful in finding integrated ways to combat the disease.

DNA methylation is an epigenetic mechanism used by cells to control gene expression. It plays an important role in many biological phenomena including development, genome stability and phenotypic plasticity. While most our current knowledge about DNA methylation comes from studying mammals, limited data exist on invertebrates, particularly mollusks. Yet, one study on Pacific oysters revealed that their genome displayed intragenic DNA methylation and that it contained the genes necessary for this epigenetic mechanism. Moreover, the role of DNA methylation in host-virus interactions and virulence is well documented, whereas less is known with regard to parasitism. In earlier articles, we discussed how the flu viruses use DNA methylation to evade the human immune system and how pathogens like the Toxoplasma parasite have the potential to similarly alter DNA methylation.

With a need for more data and the recent availability of B. glabratas DNA sequencing, the research team used a variety of diverse approaches to functionally characterize the critically important molecular process of DNA methylation in the snail species. In addition, they evaluated the mollusks responsiveness to schistosome soluble products, specifically from the more common Schistosoma mansoni genus. The mechanisms identified in their study included DNMT1, DNMT2 and methyl-CpG-binding domain protein (MBD2/3).

Using popular enzymatic assays from EpiGentek, the group measured both DNA methyltransferase and MBD binding activity within nuclear extracts derived from the tissues of 4 individual snail strains. They also quantified 5-mC levels in their global DNA pools using the companysSuperSense Methylated DNA Quantification Kit. Their results showed that MBD2/3 and DNMT1 genes were transcriptionally enriched in gonadal vs. somatic tissue, and that treatment with demethylating agent,5-azacytidine (5-AzaC), significantly inhibited egg production and embryo development. They also found higher levels or 5-mC, DNMT activity, and 5-mC binding in hybrid vs inbred snail populations. High resolution bisulfite (BS)-PCR analysis further revealed the presence of 5-mC within an exonic region of a housekeeping protein-coding gene (14-3-3), thus supporting computer simulated calculations and whole genome BS-Seq analysis previous done on this species genome.

Lastly, the researchers looked at how the parasite is able to overcome the snails immune system response. Using the B.glabrataembryonic cell line (Bge) they cultured the cells in the presence or absence of schistosome larval transformation products (LTP). Interestingly, the Bge cells exposed to schistosome LTP significantly increased their expression of both Bgdnmt1 as well as Bgmbd2/3, the authors wrote, indicating that the snails epigenetic machinery is responsive to biotic stress and is specifically reactive to parasite products. These results provide first evidence for a Schistosoma mansoni provoked modulation of the snails DNA methylation system.

While global eradication of schistosomiasis will take time, it can happen. The WHO projects that by the year 2025 this disease should be wiped out. As it stands now, however, there is no effective vaccine, only one viable drug, and the increasing risk of the pathogens territory expansion. Its clear that alternative tools to control schistosomiasis must be explored. Perhaps, disrupting the parasite during its developmental stage in snails may be the key to truly ending this epidemic.

This study is only preliminary, but the extended data it provides on B. glabrata epigenetics offers up new targets and molecular processes that should be further explored. In a parallel investigation, the same research team analyzed the snails genome, providing details on the biological properties that contribute to the snails suitability as host for the transmission of human schistosomiasis. Its optimistic that these efforts together may lead to new approaches that help control the spread of this serious neglected tropical disease, as well as other similar parasitic diseases.

Source: Geyer KK, Niazi UH, Duval D, Cosseau C, Tomlinson C, Chalmers IW, et al. (2017) The Biomphalaria glabrata DNA methylation machinery displays spatial tissue expression, is differentially active in distinct snail populations and is modulated by interactions with Schistosoma mansoni. PLoS Neglected Tropical Disease 11(5): e0005246.

Read the rest here:
Using Epigenetics to Combat a Terrible Neglected Tropical Disease - WhatIsEpigenetics.com

Posted in Epigenetics | Comments Off on Using Epigenetics to Combat a Terrible Neglected Tropical Disease – WhatIsEpigenetics.com

Page 22«..10..21222324..»